Probiotic composition for treating gynecological inflammations

A technology of gynecological inflammation and composition, which is applied in the field of probiotic composition for treating gynecological inflammation, can solve the problems of side effects of liver and kidney function, long treatment time, repeated infection, etc., and achieve a wide range of raw material sources, simple preparation process, and convenient use Effect

Inactive Publication Date: 2017-09-15
镇江市天益生物科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned therapy will inhibit the normal flora to some extent, causing excessive reproduction of pathogenic bacteria or conditional pathogenic bacteria, resulting in repeated infections or multiple infections, increasing the difficulty and cost of treatment
If the drug is used for too long, drug resistance will develop, and it will have certain side effects on liver and kidney functions, which will be more harmful to patients.
However, the use of traditional Chinese medicine or Chinese patent medicine for a long time, the treatment effect is not ideal
At present, to regulate the flora of the reproductive tract, if probiotics are used, they are generally used as suppositories for internal use, and there are few oral varieties, which is inconvenient to use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Probiotic composition for treating gynecological inflammations
  • Probiotic composition for treating gynecological inflammations
  • Probiotic composition for treating gynecological inflammations

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0081] The composition for treating gynecological inflammation comprises the following components by weight: 30 parts of resistant dextrin, 60 parts of inulin powder, 2 parts of stachyose, 0.1×10 Lactobacillus rhamnosus TR08 12 CFU, Lactobacillus reuteri TR02 10×10 12 CFU.

Embodiment 2

[0083] The composition for treating gynecological inflammation includes the following components in parts by weight: 40 parts of resistant dextrin, 40 parts of inulin powder, 8 parts of stachyose, Lactobacillus rhamnosus TR08 10×10 12 CFU, Lactobacillus reuteri TR02 0.1×10 12 CFU.

Embodiment 3

[0085] The composition for treating gynecological inflammation comprises the following components by weight: 35 parts of resistant dextrin, 50 parts of inulin powder, 5 parts of stachyose, Lactobacillus rhamnosus TR08 1×10 12 CFU, Lactobacillus reuteri TR02 1 x 10 12 CFU.

[0086] See Table 1 for the nutritional components of the compositions of Examples 1 to 3.

[0087] Table 1

[0088]

[0089]

[0090] The compositions of Examples 1 to 3 are used to treat gynecological inflammation.

[0091] Experiment 1: Treatment of bacterial vaginosis and fungal vaginitis.

[0092] Divide the population to be tested into several groups:

[0093] Healthy group:

[0094] BV group (bacterial vaginosis group):

[0095] Placebo group 1 (Placebo): treated with placebo for 28 days;

[0096] Probiotic group 1 (Probiotic): treated with the composition of Example 3 of the present invention for 28 days;

[0097] VVC group (mycotic vaginitis group):

[0098] Placebo group 2 (Placebo):...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a composition for treating gynecological inflammations. The composition comprises, by weight, 30-40 parts of resistsant dextrin, 40-60 parts of inulin, 2-8 parts of stachyose, (0.1-10) * 10<12> CFU of Lactobacillus rhamnosus TR08, and (0.1-10) * 10<12> CFU of Lactobacillus reuteri TR02. The composition has the advantages of simple preparation process, wide sources of raw materials, low cost, convenience in use, and good gynecological inflammation treatment effect.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to a probiotic composition for treating gynecological inflammation. Background technique [0002] Gynecological inflammation refers to the disease caused by women's reproductive system infection. Gynecological inflammation is a common disease and a stubborn disease in daily life, especially among married women. The common symptoms are irregular menstruation, dysmenorrhea, and annex inflammation. , pelvic inflammatory disease, cervicitis, endometritis, abnormal vaginal discharge with peculiar smell, etc., and some even cause infertility. Gynecological inflammation has a high prevalence rate and a high recurrence rate, which seriously affects women's physical and mental health. [0003] A variety of female lower reproductive tract diseases are caused by the imbalance of vaginal micro-ecological system, such as bacterial vaginosis, fungal vaginitis, trichomonas vaginitis and so on. The c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/747A61P15/00A61P15/02A61P31/04A61P31/10A61K31/733A61K31/702A61K31/716A61K31/7048A61K31/43A61K31/7052A61K31/546A61K31/65A61K31/4164
CPCA61K31/4164A61K31/43A61K31/546A61K31/65A61K31/702A61K31/7048A61K31/7052A61K31/716A61K31/733A61K35/747A61K2300/00
Inventor 李珮铷贾长生边高瑞
Owner 镇江市天益生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap